The therapies now approved for human immunodeficiency virus type 1 (HIV-1) infection inhibit one of two viral-specific enzymes, reverse transcriptase or protease 1. Although several combination ...
†Institute of Electronics, Microelectronics, and Nanotechnology (IEMN, UMR CNRS 8520), Université Lille 1, Cité Scientifique, Avenue Poincaré, BP60069, 59652 Villeneuve d’Ascq, France ‡ Laboratoire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results